+

WO2009108364A3 - Antagonistic analogues of ghrh - Google Patents

Antagonistic analogues of ghrh Download PDF

Info

Publication number
WO2009108364A3
WO2009108364A3 PCT/US2009/001279 US2009001279W WO2009108364A3 WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3 US 2009001279 W US2009001279 W US 2009001279W WO 2009108364 A3 WO2009108364 A3 WO 2009108364A3
Authority
WO
WIPO (PCT)
Prior art keywords
analogues
hghrh
inhibit
ghrh
antagonistic
Prior art date
Application number
PCT/US2009/001279
Other languages
French (fr)
Other versions
WO2009108364A2 (en
Inventor
Zheng Xin Dong
Daniel B. Deoliveira
Original Assignee
Ipsen Pharma S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma S.A.S. filed Critical Ipsen Pharma S.A.S.
Publication of WO2009108364A2 publication Critical patent/WO2009108364A2/en
Publication of WO2009108364A3 publication Critical patent/WO2009108364A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/60Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

There is provided a novel series of synthetic antagonistic analogues of hGHRH(l- 29)NH2 (SEQ E) NO: 1). These analogues inhibit the activity of endogenous hGHRH on the pituitary GHRH receptors, and therefore prevent the release of growth hormone. The analogues also inhibit the proliferation of human cancers through a direct effect on the cancer cells. The inhibitory potencies of the new analogues result from replacement of various amino acids.
PCT/US2009/001279 2008-02-27 2009-02-27 Antagonistic analogues of ghrh WO2009108364A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6731808P 2008-02-27 2008-02-27
US61/067,318 2008-02-27
US20736609P 2009-02-11 2009-02-11
US61/207,366 2009-02-11

Publications (2)

Publication Number Publication Date
WO2009108364A2 WO2009108364A2 (en) 2009-09-03
WO2009108364A3 true WO2009108364A3 (en) 2010-01-07

Family

ID=41016657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/001279 WO2009108364A2 (en) 2008-02-27 2009-02-27 Antagonistic analogues of ghrh

Country Status (1)

Country Link
WO (1) WO2009108364A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113929761B (en) * 2020-03-18 2024-02-20 深圳纳福生物医药有限公司 Modification and dimerization preparation of new growth hormone-releasing hormone-like peptides and their applications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US20050148515A1 (en) * 2002-08-09 2005-07-07 Dong Zheng X. Growth hormone releasing peptides
US20070042950A1 (en) * 2003-08-05 2007-02-22 Administrators Of The Tulane Educational Fund, The Antagonistic analogs of gh rh (2003)

Also Published As

Publication number Publication date
WO2009108364A2 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
WO2005016953A3 (en) Antagonistic analogs of gh-rh (2003)
WO2006005140A3 (en) Proteinaceous compounds and uses therefor
SI1551511T1 (en) Heterocyclic aromatic compounds useful as growth hormone secretagogues
GT201200236A (en) AGONIST POLYPEPTIDES THAT LINK TO DR5
GB2436265A (en) Formulations of human growth hormone comprising a non-naturally encoded amino acid
HK1138011A1 (en) Template-fixed peptidomimetics
WO2006113452A3 (en) Glycoprotein hormone analogs
WO2009120831A3 (en) Novel n-and c-terminal substituted -antagonistic analogs of human gh-rh
TW200614987A (en) Novel compounds
MX2009008561A (en) Method of treating cell proliferative disorders using growth hormone secretagogues.
WO2009108364A3 (en) Antagonistic analogues of ghrh
NZ592670A (en) Corticotrophin releasing hormone receptor 2 peptide agonists and uses thereof
MXPA05013465A (en) Cis-imidazolines as mdm2 inhibitors.
WO2005066207A8 (en) Glucagon-like peptide-1 analogs with long duration of action
WO2006113828A3 (en) Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
WO2003087069A3 (en) Dipeptidic growth hormone secretagogues
PH12013502021A1 (en) Platelet aggregation inhibitor composition
EP2129359A4 (en) Chimeric peptide antagonist for gpcr135 or gpcr142
WO2007033211A3 (en) Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases
WO2020014307A8 (en) Peptide-based inhibitors of growth hormone action and methods of use thereof
WO2007139820A3 (en) Inhibition of skp2-cyclin a interaction
WO2012131680A3 (en) Compositions and methods for treating inflammation based on inhibiting cd151 activity
WO2013114363A3 (en) Antimicrobial agents
HK1121681A1 (en) Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
TW200617021A (en) Isolated photoprotein aequorin y89f, and its use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09714255

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载